Predictors of Intracranial Hemorrhage in ARDS Patients on ECMO

Charite University, Berlin, Germany1,000 enrolled

Overview

Intracranial hemorrhage is is a rare, but critical incident in patients with acute lung failure undergoing ECMO therapy. Predictors of intracranial hemorrhage are yet to be defined to identify patients at (high) risk. This retrospective analysis investigates the predictive value and validity of parameters and specific risk factors of critically ill ARDS patients treated with ECMO.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

ARDS, Human Extracorporeal Membrane Oxygenation Complication

Interventions

complication versus no complicationOTHER

development of ICH

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ARDS following Berlin definition (mild, moderate, severe) * ECMO therapy (veno-venous cannulation) Exclusion Criteria: * ECMO, other than VV * ICH at initiation of ECMO * no cerebral CT scan at any time

Locations (1)

Charite university medicine Berlin

Berlin, Germany

RECRUITING

Outcomes

Primary Outcomes

mortality

mortality after ICH/no ICH in ARDS patients with ECMO

Time frame: up to 28 days

Secondary Outcomes

ICU stay

days on ICU

Time frame: up to 28 days

ventilator/ECMO-free days

Ventilator/ECMO-free days

Time frame: up to 28 days

Central Contacts

Mario Menk, PD Dr med

CONTACT

+4930450551002 mario.menk@charite.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.